pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

32 catalysts · 14 approval · 9 device 510k · 7 device pma · 2 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 28 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-11-04×to 2025-11-04×clear all
type
  • approval14
  • device 510k9
  • device pma7
  • device recall2
therapy area

no tagged catalysts yet

Week of Nov 3, 2025

32
›
Nov 4, 2025
approval
284d ago
MEDROL (METHYLPREDNISOLONE) — FDA approvalMEDROL

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →MEDROL →fda approvals ↗
›Nov 4, 2025approval284d agoISOFLURANE — FDA approvalSedana Medical AB

Sponsor: SHANDONG. Form: LIQUID. Route: INHALATION

full page →fda approvals ↗
›Nov 4, 2025approval284d agoMARAVIROC — FDA approvalForest Hills Partners Hong Kong Ltd

Sponsor: RHODES PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Nov 4, 2025approval284d agoDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalMETHYLPREDNISOLONE ACETATE

Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗
›Nov 4, 2025approval284d agoIRBESARTAN — FDA approvalIRBESARTAN

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →IRBESARTAN →fda approvals ↗
›Nov 4, 2025approval284d agoPHYTONADIONE — FDA approvalPHYTONADIONE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →PHYTONADIONE →fda approvals ↗
›Nov 4, 2025approval284d agoLOPROX (CICLOPIROX) — FDA approvalATLAS Molecular Pharma SL

Sponsor: EUROFARMA. Form: SUSPENSION. Route: TOPICAL

full page →fda approvals ↗
›Nov 4, 2025approval284d agoSULFASALAZINE — FDA approvalsulfasalazine DR

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →sulfasalazine DR →fda approvals ↗
›Nov 4, 2025approval284d agoISTURISA (OSILODROSTAT PHOSPHATE) — FDA approvalosilodrostat phosphate

Sponsor: RECORDATI RARE. Form: TABLET. Route: ORAL

full page →osilodrostat phosphate →fda approvals ↗
›Nov 4, 2025approval284d agoMIRABEGRON — FDA approvalmirabegron ER

Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →mirabegron ER →fda approvals ↗
›Nov 4, 2025approval284d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗
›Nov 4, 2025approval284d agoLOPROX (CICLOPIROX) — FDA approvalATLAS Molecular Pharma SL

Sponsor: EUROFARMA. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗
›Nov 4, 2025approval284d agoSOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) — FDA approvalmethylprednisolone sodium succinate

Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION

full page →methylprednisolone sodium succinate →fda approvals ↗
›Nov 4, 2025approval284d agoLINZESS (LINACLOTIDE) — FDA approvallinaclotide

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →linaclotide →fda approvals ↗
›Nov 4, 2025device 510k284d agoGM Dos Reis Industria e Comercio Ltda. — GMReis Suture Anchors (510k cleared)

Product code: MBI. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoPrimed Medical Products, Inc. — PRIMED Surgical and Procedure Masks (510k cleared)UTAH MEDICAL PRODUCTS INC

Product code: FXX. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoKarma Mobility Co, Ltd. — Flexx Junior (FLX-J00, FLX-J50) (510k cleared)

Product code: IOR. Advisory committee: Physical Medicine. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoVieworks Co., Ltd. — VXvue (510k cleared)

Product code: LLZ. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoMedcad — MedCAD® AccuStride™ System (510k cleared)

Product code: PBF. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoApplied Medical Resources Corp. — Voyant® Open Fusion Device (EB240/Open Fusion) (510k cleared)

Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Special

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoMerit Medical Systems, Inc. — Merit Syringe (510k cleared)MERIT MEDICAL SYSTEMS INC

Product code: FMF. Advisory committee: General Hospital. Type: Special

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoMenovex Medical Technology (Shenzhen) Co., Ltd. — Tamburo Thulium Fiber Laser System (510k cleared)NewBay Medical Technology Co Ltd

Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device 510k284d agoSiemens Medical Solutions USA, Inc. — Cios Select (510k cleared)

Product code: OWB. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Nov 4, 2025device pma284d agoQ-Med AB — Restylane® Lyft with Lidocaine (PMA supplement)Sustained Therapeutics Inc

Supplement type: Panel Track. Product code: LMH. Advisory committee: SU. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device pma284d agoMedtronic Neuromodulation — Master Restore™, Itrel™, Synergy Intellis™, Vanta™ and Inceptiv™ Spinal Cord Stimulation Systems and Pisces™, Specify™, (PMA supplement)

Supplement type: Real-Time Process. Product code: LGW. Advisory committee: NE. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device pma284d agoMedtronic Neuromodulation — nterStim™ Therapy System, Verify™ Evaluation System (PMA supplement)

Supplement type: Real-Time Process. Product code: QON. Advisory committee: GU. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device pma284d agoMedtronic Neuromodulation — InterStim™ Therapy System, Verify™ Evaluation System (PMA supplement)

Supplement type: Real-Time Process. Product code: EZW. Advisory committee: GU. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device pma284d agoABBOTT MEDICAL — HeartMate 3™ Left Ventricular Assist System (LVAS) (PMA supplement)

Supplement type: Real-Time Process. Product code: DSQ. Advisory committee: CV. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device pma284d agoETHICON, Inc. — SURGICEL® Absorbable Hemostats (PMA supplement)

Supplement type: Real-Time Process. Product code: LMG. Advisory committee: SU. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device pma284d agoMedtronic, Inc. — Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (PMA supplement)Medtronic plc

Supplement type: Real-Time Process. Advisory committee: NE. Decision: APPR

full page →fda device pma ↗
›Nov 4, 2025device recall284d agoDatascope Corp. device recall (Cls II)

Cardiosave Rescue. Intra-Aortic Balloon Pump system. — Reason: The IFU addendum revises the Preventative Maintenance schedule to align with the update introduced in the Service Manual as of June 2023. — Status: Ongoing

full page →fda device recalls ↗
›Nov 4, 2025device recall284d agoDatascope Corp. device recall (Cls II)

Cardiosave Hybrid. Intra-Aortic Balloon Pump system. — Reason: The IFU addendum revises the Preventative Maintenance schedule to align with the update introduced in the Service Manual as of June 2023. — Status: Ongoing

full page →fda device recalls ↗
$AMRX17.27-2.21%
$AMRX17.27-2.21%
$PFE26.61-0.73%
$PFE26.61-0.73%
$MDT90.58-0.20%
$ABBV250.82+0.83%
$MMSI90.31-0.21%
$UTMD69.19+0.06%